215 related articles for article (PubMed ID: 23237561)
1. Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.
Han SS; Son DJ; Yun H; Kamberos NL; Janz S
Leuk Res; 2013 Feb; 37(2):146-54. PubMed ID: 23237561
[TBL] [Abstract][Full Text] [Related]
2. Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells.
Han SS; Tompkins VS; Son DJ; Kamberos NL; Stunz LL; Halwani A; Bishop GA; Janz S
Biochem Biophys Res Commun; 2013 Jul; 436(4):660-5. PubMed ID: 23764397
[TBL] [Abstract][Full Text] [Related]
3. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
4. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Emodin Derivative on Cell Cycle, Apoptosis and NF-κB Pathway in Burkitt Lymphoma Cells].
Cheng DF; Yang BX; Liu WJ; Qiu CX; Liao JR; Qiu YY; Liu TB; Hu JD; Wang WF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):474-488. PubMed ID: 33812418
[TBL] [Abstract][Full Text] [Related]
6. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro.
Chen S; Wang Z; Dai X; Pan J; Ge J; Han X; Wu Z; Zhou X; Zhao T
Cancer Sci; 2013 Jul; 104(7):826-34. PubMed ID: 23521217
[TBL] [Abstract][Full Text] [Related]
7. Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal model.
Wang T; Xu P; Wang F; Zhou D; Wang R; Meng L; Wang X; Zhou M; Chen B; Ouyang J
Leuk Lymphoma; 2017 Jul; 58(7):1673-1685. PubMed ID: 28084852
[TBL] [Abstract][Full Text] [Related]
8. Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway.
Zheng J; Son DJ; Gu SM; Woo JR; Ham YW; Lee HP; Kim WJ; Jung JK; Hong JT
Sci Rep; 2016 May; 6():26357. PubMed ID: 27198178
[TBL] [Abstract][Full Text] [Related]
9. Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.
Awasthee N; Shekher A; Rai V; Verma SS; Mishra S; Dhasmana A; Gupta SC
Apoptosis; 2022 Apr; 27(3-4):261-282. PubMed ID: 35122181
[TBL] [Abstract][Full Text] [Related]
10. Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells.
Ginzburg S; Golovine KV; Makhov PB; Uzzo RG; Kutikov A; Kolenko VM
Prostate; 2014 Feb; 74(2):177-86. PubMed ID: 24151226
[TBL] [Abstract][Full Text] [Related]
11. Decitabine represses translocated MYC oncogene in Burkitt lymphoma.
Guan H; Xie L; Klapproth K; Weitzer CD; Wirth T; Ushmorov A
J Pathol; 2013 Apr; 229(5):775-83. PubMed ID: 23341364
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
Kumar S; Agnihotri N
Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
[TBL] [Abstract][Full Text] [Related]
13. The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
Klapproth K; Sander S; Marinkovic D; Baumann B; Wirth T
Blood; 2009 Sep; 114(12):2448-58. PubMed ID: 19628709
[TBL] [Abstract][Full Text] [Related]
14. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
15. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.
Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
17. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
18. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
19. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
[TBL] [Abstract][Full Text] [Related]
20. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
